Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2016

30.07.2016 | ORIGINAL ARTICLE

Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement

verfasst von: J. Perinel, G. Nappo, M. El Bechwaty, T. Walter, V. Hervieu, P. J. Valette, P. Feugier, M. Adham

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

Pancreatectomy with arterial resection for locally advanced pancreatic duct adenocarcinoma (PDA) is associated with high morbidity and is thus considered as a contraindication. The aim of our study was to report our experience of pancreatectomy with planned arterial resection for locally advanced PDA based on specific selection criteria.

Material and methods

All patients receiving pancreatectomy for PDA between October 2008 and July 2014 were reviewed. The patients were classified into group 1, pancreatectomy without vascular resection (66 patients); group 2, pancreatectomy with isolated venous resection (31 patients), and group 3, pancreatectomy with arterial resection for locally advanced PDA (14 patients). The primary selection criteria for arterial resection was the possibility of achieving a complete resection based on the extent of axial encasement, the absence of tumor invasion at the origin of celiac trunk (CT) and superior mesenteric artery (SMA), and a free distal arterial segment allowing reconstruction. Patient outcomes and survival were analyzed.

Results

Six SMA, two CT, four common hepatic artery, and two replaced right hepatic artery resections were undertaken. The preferred arterial reconstruction was splenic artery transposition. Group 3 had a higher preoperative weight loss, a longer operative time, and a higher incidence of intraoperative blood transfusion. Ninety-day mortality occurred in three patients in groups 1 and 2. There were no statistically significant differences in the incidence, grade, and type of complications in the three groups. Postoperative pancreatic fistula and postpancreatectomy hemorrhage were also comparable. In group 3, none had arterial wall invasion and nine patients had recurrence (seven metastatic and two loco-regional). Survival and disease-free survival were comparable between groups.

Conclusion

Planned arterial resection for PDA can be performed safely with a good outcome in highly selected patients. Key elements for defining the resectability is based on the extent of the axial arterial encasement with two criteria: the origin of the CT and SMA are free from tumor invasion and the possibility of distal reconstruction.
Literatur
1.
2.
Zurück zum Zitat Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921. doi:10.1158/0008-5472.CAN-14-0155 CrossRefPubMed Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921. doi:10.​1158/​0008-5472.​CAN-14-0155 CrossRefPubMed
3.
Zurück zum Zitat Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277. doi:10.1001/jama.297.3.267 CrossRefPubMed Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277. doi:10.​1001/​jama.​297.​3.​267 CrossRefPubMed
4.
Zurück zum Zitat Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, et al. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery 156:1–14. doi:10.1016/j.surg.2014.02.009 Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, et al. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery 156:1–14. doi:10.​1016/​j.​surg.​2014.​02.​009
5.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366 . doi:10.1097/01.SLA.0000027272.08464.0Bdiscussion 366–8CrossRefPubMedPubMedCentral Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366 . doi:10.​1097/​01.​SLA.​0000027272.​08464.​0Bdiscussion 366–8CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618–628 . doi:10.1016/j.surg.2005.06.044discussion 628–30CrossRefPubMed Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618–628 . doi:10.​1016/​j.​surg.​2005.​06.​044discussion 628–30CrossRefPubMed
7.
Zurück zum Zitat Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273. doi:10.1002/bjs.5716 CrossRefPubMed Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273. doi:10.​1002/​bjs.​5716 CrossRefPubMed
9.
Zurück zum Zitat Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. (2012) Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 255:103–108. doi:10.1097/SLA.0b013e318237872e CrossRefPubMed Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. (2012) Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 255:103–108. doi:10.​1097/​SLA.​0b013e318237872e​ CrossRefPubMed
10.
12.
Zurück zum Zitat Gooiker GA, Van Gijn W, Wouters MWJM, Post PN, Van De Velde CJH, Tollenaar RAEM, et al. (2011) Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg 98:485–494. doi:10.1002/bjs.7413 CrossRefPubMed Gooiker GA, Van Gijn W, Wouters MWJM, Post PN, Van De Velde CJH, Tollenaar RAEM, et al. (2011) Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg 98:485–494. doi:10.​1002/​bjs.​7413 CrossRefPubMed
14.
Zurück zum Zitat Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046. doi:10.1245/ASO.2006.08.011 CrossRefPubMed Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046. doi:10.​1245/​ASO.​2006.​08.​011 CrossRefPubMed
17.
Zurück zum Zitat Tol JAMG, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, et al. (2014) Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 156:591–600. doi:10.1016/j.surg.2014.06.016 CrossRefPubMed Tol JAMG, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, et al. (2014) Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 156:591–600. doi:10.​1016/​j.​surg.​2014.​06.​016 CrossRefPubMed
18.
Zurück zum Zitat Wolinsky FD, Coe RM, McIntosh WA, Kubena KS, Prendergast JM, Chavez MN, et al. (1990) Progress in the development of a nutritional risk index. J Nutr 120(Suppl 11):1549–1553PubMed Wolinsky FD, Coe RM, McIntosh WA, Kubena KS, Prendergast JM, Chavez MN, et al. (1990) Progress in the development of a nutritional risk index. J Nutr 120(Suppl 11):1549–1553PubMed
21.
Zurück zum Zitat Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study Group of Liver Surgery. Surgery 149:680–688. doi: 10.1016/j.surg.2010.12.002 Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study Group of Liver Surgery. Surgery 149:680–688. doi: 10.​1016/​j.​surg.​2010.​12.​002
23.
Zurück zum Zitat Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768. doi:10.1016/j.surg.2007.05.005 CrossRefPubMed Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768. doi:10.​1016/​j.​surg.​2007.​05.​005 CrossRefPubMed
25.
Zurück zum Zitat Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988. doi:10.1016/j.surg.2014.02.001 CrossRefPubMed Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988. doi:10.​1016/​j.​surg.​2014.​02.​001 CrossRefPubMed
27.
Zurück zum Zitat Amano H, Miura F, Toyota N, Wada K, Katoh K-I, Hayano K, et al. (2009) Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepato-Biliary-Pancreat Surg 16:850–857. doi:10.1007/s00534-009-0190-7 CrossRef Amano H, Miura F, Toyota N, Wada K, Katoh K-I, Hayano K, et al. (2009) Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepato-Biliary-Pancreat Surg 16:850–857. doi:10.​1007/​s00534-009-0190-7 CrossRef
28.
Zurück zum Zitat Bachellier P, Rosso E, Lucescu I, Oussoultzoglou E, Tracey J, Pessaux P, et al. (2010) Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol 103:75–84. doi:10.1002/jso.21769 CrossRef Bachellier P, Rosso E, Lucescu I, Oussoultzoglou E, Tracey J, Pessaux P, et al. (2010) Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol 103:75–84. doi:10.​1002/​jso.​21769 CrossRef
29.
32.
Zurück zum Zitat Appleby LH (1953) The coeliac Axis in the expansion of the operation for gastric carcinoma. Cancer 6:704–707CrossRefPubMed Appleby LH (1953) The coeliac Axis in the expansion of the operation for gastric carcinoma. Cancer 6:704–707CrossRefPubMed
33.
Zurück zum Zitat Portolani N, Tiberio GAM, Coniglio A, Baiocchi G, Vettoretto N, Giulini SM (2004) Emergency celiac revascularization for supramesocolic ischemia during pancreaticoduodenectomy: report of a case. Surg Today 34:616–618. doi:10.1007/s00595-004-2755-z CrossRefPubMed Portolani N, Tiberio GAM, Coniglio A, Baiocchi G, Vettoretto N, Giulini SM (2004) Emergency celiac revascularization for supramesocolic ischemia during pancreaticoduodenectomy: report of a case. Surg Today 34:616–618. doi:10.​1007/​s00595-004-2755-z CrossRefPubMed
34.
Zurück zum Zitat Swanson RS, Pezzi CM, Mallin K, Loomis AM, Winchester DP (2014) The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the National Cancer Data Base. Ann Surg Oncol 21:4059–4067. doi:10.1245/s10434-014-4036-4 CrossRefPubMed Swanson RS, Pezzi CM, Mallin K, Loomis AM, Winchester DP (2014) The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the National Cancer Data Base. Ann Surg Oncol 21:4059–4067. doi:10.​1245/​s10434-014-4036-4 CrossRefPubMed
36.
Zurück zum Zitat Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, et al. (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309. doi:10.1097/SLA.0b013e31815aab22 CrossRefPubMed Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, et al. (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309. doi:10.​1097/​SLA.​0b013e31815aab22​ CrossRefPubMed
39.
Zurück zum Zitat Addeo P, Rosso E, Fuchshuber P, Oussoultzoglou E, De Blasi V, Simone G, et al. (2015) Resection of borderline resectable and locally advanced pancreatic adenocarcinomas after neoadjuvant chemotherapy. Oncology 89:37–46. doi:10.1159/000371745 CrossRefPubMed Addeo P, Rosso E, Fuchshuber P, Oussoultzoglou E, De Blasi V, Simone G, et al. (2015) Resection of borderline resectable and locally advanced pancreatic adenocarcinomas after neoadjuvant chemotherapy. Oncology 89:37–46. doi:10.​1159/​000371745 CrossRefPubMed
40.
Zurück zum Zitat Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PWT (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1751–1756. doi:10.1245/s10434-009-0413-9 CrossRefPubMed Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PWT (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1751–1756. doi:10.​1245/​s10434-009-0413-9 CrossRefPubMed
42.
Zurück zum Zitat Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, et al. (2015) FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas 44:515–521. doi:10.1097/MPA.0000000000000314 CrossRefPubMed Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, et al. (2015) FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas 44:515–521. doi:10.​1097/​MPA.​0000000000000314​ CrossRefPubMed
43.
Zurück zum Zitat Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, et al. (2015) Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer. Langenbeck’s Arch Surg 400:477–485. doi:10.1007/s00423-015-1304-0 CrossRef Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, et al. (2015) Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer. Langenbeck’s Arch Surg 400:477–485. doi:10.​1007/​s00423-015-1304-0 CrossRef
47.
Metadaten
Titel
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement
verfasst von
J. Perinel
G. Nappo
M. El Bechwaty
T. Walter
V. Hervieu
P. J. Valette
P. Feugier
M. Adham
Publikationsdatum
30.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2016
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1488-y

Weitere Artikel der Ausgabe 8/2016

Langenbeck's Archives of Surgery 8/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.